English (US)
Translating Cutting-Edge Science into Health and Longevity Solutions
Cutting-edge technologies for health optimization and aging intervention from leading research institutions worldwide are integrated into data-driven, personalized health and longevity solutions.
Learn More ›
Cutting-Edge Multi-Omics Platform for Biological Pathway Analysis
By integrating multi-omics technologies with biological pathway analysis, the platform enables multidimensional profiling of human health and aging.
Learn More ›
AI-Powered Biomedical Applications Platform
Large-scale AI models, advanced algorithms, and bioinformatics enable more efficient drug discovery and development, as well as smarter healthcare solutions.
Learn More ›
Gene Therapy Pipeline
Early-stage R&D programs explore cutting-edge fields such as gene editing, cellular reprogramming, and immunotherapy, with a focus on project development and validation of proposed technical approaches.
Learn More ›
AI-Powered Biomedical Applications Platform
Leveraging advanced large AI models, algorithms, and bioinformatics to substantially enhance R&D efficiency—and drawing on the scientific thinking and deep expertise of world-leading scientists—we are building a professional-grade health intelligence expert. The ESTOREL AI-Powered Biomedical Applications Platform bridges two domains. One is health services, represented by an application-side professional health intelligence expert system whose depth of expertise in delivering consumer health consultations in aging far exceeds that of conventional AI chatbots and online medical consultations. The other is cutting-edge biomedical technology R&D, where the platform accelerates AI-driven drug discovery from target prediction through to candidate molecule generation—substantially improving both R&D efficiency and R&D success rates.
A Pipeline from Today to Tomorrow
Prime editing, often described as a genetic “search-and-replace” tool, entered its first-in-human clinical application in 2025. Partial cellular reprogramming, sometimes described as a form of cellular “rejuvenation,” advanced into the world's first human clinical trial in 2026. Both technologies remain at an early stage of clinical development. We rigorously evaluate each candidate program across multiple dimensions, including mechanistic rationale, delivery efficiency, safety, and regulatory feasibility.
New ESTOREL
ESTOREL is a global biotechnology company focused on aging and longevity research. Building on our R&D capabilities in this field, we are committed to translating cutting-edge longevity science into practical health intervention pathways that everyone can understand, put into practice, and track over time.
Gene Therapy Pipeline
With advancing age, defects in gene function can arise as cells process genetic information, impairing the body’s ability to produce proteins required for normal physiological function and contributing to age-related diseases and metabolic disorders. Gene therapy works by delivering functional gene copies to target cells—restoring or compensating for defective gene function and helping cells return to normal physiological activity.
Learn More ›
Representative Products and R&D Pipeline
Aging is not driven by a single deficiency, but involves interconnected changes across multiple biological systems, including nutrient sensing, energy metabolism, mitochondrial function, cellular clearance, oxidative stress, and neuroimmune regulation. ESTOREL’s oral intervention R&D goes beyond a single-ingredient approach to understand how these systems change and interact. We start with a multi-target, multi-pathway design and progressively evaluate its performance through rigorous quality management, user adherence, predefined assessment endpoints, and human studies.
Learn More ›Our Global Vision
Our Mission
Making healthy longevity accessible to everyone.
Our Purpose
Grounded in scientific evidence, we translate cutting-edge longevity research into measurable, trackable approaches to aging and disease intervention.
Our Belief
Committed to advancing biomedical innovation to improve quality of life and extend healthspan for all.
Hallmarks of Aging ›
Biological pathway omics is an analytical approach that integrates multidimensional data across genomics, proteomics, and metabolomics and interprets it systematically at the level of biological pathways. Conventional single-omics testing can be thought of as an item-by-item checklist, whereas pathway omics is more akin to understanding an entire assembly line: it maps molecular data from different layers onto established biological pathway databases such as KEGG, Reactome, and WikiPathways and, through pathway enrichment analysis, cross-omics network construction, and machine learning modeling, moves from a list of molecules to a pathway network—identifying coordinated changes across omics layers at the pathway level. Its core distinction lies in revealing not only changes in individual molecules but also systemic perturbations at the pathway level, thereby providing interpretable mechanistic insights into complex biological processes.
Evidence and Translation ›
ESTOREL has established a five-stage translational pathway, with external communications tailored to the level of validation achieved at each stage.
Technology Landscape ›
Drawing on ESTOREL’s specialized screening platform, we systematically integrate core aging intervention technologies from leading research institutions worldwide and continuously update this portfolio based on experimental validation progress and global developments across relevant fields.
Health and Longevity Solutions for Every Life Stage
ESTOREL brings together next-generation approaches to aging and disease intervention, systemic oral solutions, and personalized intervention plans to create an integrated, closed-loop approach to health and longevity.
Our Oral Solutions
Moving beyond traditional single-ingredient supplementation, we develop oral solutions designed to address multiple biological targets and pathways.
Personalized Health Intervention Plans
By connecting oral interventions, testing and retesting, and personalized care plans, we build a continuous, closed-loop approach to health management, which makes progress measurable, insights understandable, interventions actionable, and outcomes trackable over time.
Next-Generation Approaches to Aging and Disease Intervention
Advancing early-stage R&D programs and translational research in emerging fields such as gene editing, cell therapy, immunotherapy, and targeted therapeutics.